These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

824 related items for PubMed ID: 9708461

  • 1. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV, Michaels AD, Maynard C, Every NR.
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [Abstract] [Full Text] [Related]

  • 2. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
    Michaels AD, Maynard C, Every NR, Barron HV.
    Am J Cardiol; 1999 Nov 15; 84(10):1176-81. PubMed ID: 10569326
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.
    Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M.
    Am J Med; 2001 Apr 15; 110(6):425-33. PubMed ID: 11331052
    [Abstract] [Full Text] [Related]

  • 4. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC, Erskine N, McManus DD, Lessard D, Gore JM, Yarzebski J, Goldberg RJ.
    Am J Cardiol; 2016 Dec 15; 118(12):1792-1797. PubMed ID: 27743577
    [Abstract] [Full Text] [Related]

  • 5. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
    Krumholz HM, Vaccarino V, Ellerbeck EF, Kiefe C, Hennen J, Kresowik TF, Gold JA, Jencks SF, Radford MJ.
    Am J Cardiol; 1997 Mar 01; 79(5):581-6. PubMed ID: 9068512
    [Abstract] [Full Text] [Related]

  • 6. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
    Berger AK, Duval S, Krumholz HM.
    J Am Coll Cardiol; 2003 Jul 16; 42(2):201-8. PubMed ID: 12875751
    [Abstract] [Full Text] [Related]

  • 7. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.
    Martínez M, Agustí A, Arnau JM, Vidal X, Laporte JR.
    Eur J Clin Pharmacol; 1998 May 16; 54(3):203-8. PubMed ID: 9681660
    [Abstract] [Full Text] [Related]

  • 8. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital.
    Mitra S, Findley K, Frohnapple D, Mehta JL.
    Clin Cardiol; 2002 Jan 16; 25(1):16-8. PubMed ID: 11808833
    [Abstract] [Full Text] [Related]

  • 9. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM.
    Am Heart J; 1999 Jan 16; 137(1):79-92. PubMed ID: 9878939
    [Abstract] [Full Text] [Related]

  • 10. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.
    Am Heart J; 2003 Mar 16; 145(3):438-44. PubMed ID: 12660666
    [Abstract] [Full Text] [Related]

  • 11. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).
    Schuler J, Maier B, Behrens S, Thimme W.
    Clin Res Cardiol; 2006 Jul 16; 95(7):360-7. PubMed ID: 16741630
    [Abstract] [Full Text] [Related]

  • 12. Medication performance measures and mortality following acute coronary syndromes.
    Granger CB, Steg PG, Peterson E, López-Sendón J, Van de Werf F, Kline-Rogers E, Allegrone J, Dabbous OH, Klein W, Fox KA, Eagle KA, GRACE Investigators.
    Am J Med; 2005 Aug 16; 118(8):858-65. PubMed ID: 16084178
    [Abstract] [Full Text] [Related]

  • 13. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
    Wu AH, Parsons L, Every NR, Bates ER, Second National Registry of Myocardial Infarction.
    J Am Coll Cardiol; 2002 Oct 16; 40(8):1389-94. PubMed ID: 12392826
    [Abstract] [Full Text] [Related]

  • 14. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA, Kulinskaya E, Steel N.
    BMJ Open; 2017 Jan 24; 7(1):e013570. PubMed ID: 28119386
    [Abstract] [Full Text] [Related]

  • 15. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.
    Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology.
    Eur Heart J; 2003 Mar 24; 24(5):464-74. PubMed ID: 12633547
    [Abstract] [Full Text] [Related]

  • 16. [Early treatment of acute myocardial infarct: implementation of therapy guidelines in routine clinical practice, MITRA pilot phase].
    Schuster S, Koch A, Burczyk U, Schiele R, Wagner S, Zahn R, Glunz HG, Heinrich F, Stuby K, Berg G, Voigtländer T, Gieseler U, Jakob M, Hauptmann P, Senges J.
    Z Kardiol; 1997 Apr 24; 86(4):273-83. PubMed ID: 9235799
    [Abstract] [Full Text] [Related]

  • 17. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.
    Frances CD, Noguchi H, Massie BM, Browner WS, McClellan M.
    Arch Intern Med; 2000 Sep 25; 160(17):2645-50. PubMed ID: 10999979
    [Abstract] [Full Text] [Related]

  • 18. Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction.
    Krumholz HM, Chen YT, Wang Y, Radford MJ.
    Arch Intern Med; 2001 Feb 26; 161(4):538-44. PubMed ID: 11252112
    [Abstract] [Full Text] [Related]

  • 19. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D, Paris BE, Aronow WS.
    J Am Geriatr Soc; 1997 Jul 26; 45(7):809-12. PubMed ID: 9215330
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Peterson JG, Topol EJ, Sapp SK, Young JB, Lincoff AM, Lauer MS.
    Am J Med; 2000 Oct 01; 109(5):371-7. PubMed ID: 11020393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.